Shares of BioRem Inc. (CVE:BRM - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as C$3.45 and last traded at C$3.35, with a volume of 141939 shares trading hands. The stock had previously closed at C$3.22.
Analyst Ratings Changes
Separately, Cormark upgraded shares of BioRem to a "moderate buy" rating in a research note on Tuesday, December 17th.
Check Out Our Latest Report on BRM
BioRem Stock Up 4.0 %
The business's 50 day simple moving average is C$2.99 and its 200 day simple moving average is C$2.52. The company has a current ratio of 1.57, a quick ratio of 1.08 and a debt-to-equity ratio of 48.97. The firm has a market capitalization of C$52.60 million, a PE ratio of 15.95 and a beta of 0.85.
Insider Transactions at BioRem
In other BioRem news, Director Derek Webb sold 120,000 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00. Corporate insiders own 1.90% of the company's stock.
BioRem Company Profile
(
Get Free Report)
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
Featured Stories
Before you consider BioRem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRem wasn't on the list.
While BioRem currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.